Comments
Commented by Carsten Mainitz on August 5th, 2021 | 10:29 CEST
JinkoSolar, Kainantu Resources, SoftBank - These stocks will rise!
The economic outlook for Asian economies is quite varied. The picture is differentiated depending on containment measures, the speed and effectiveness of vaccine deployment, external demand, and a range of economic policy conditions. The IMF forecasts economic growth of 8.2% for the People's Republic of China in the current year. Growth of 5.1% is forecast for Singapore. The IMF believes that Japan will only achieve economic growth of 2.3% in the current year, while the government itself has formulated an increase of up to 4%. With the following companies, you can profit from the expansion of the Asian markets.
Read
Commented by Armin Schulz on August 4th, 2021 | 13:12 CEST
Alibaba, Memiontec, Tencent - China, the upcoming super economic power
China defied the pandemic in 2020. In contrast to all other industrialized nations, some of whose economies suffered considerable losses, China's economic growth increased. By 2028 at the latest, China will be the world's largest economy. Today, the country is already the leading trading partner for many countries, such as Germany, Japan and Australia. China used to copy Western products, but today it is on par technologically, both in terms of artificial intelligence and 5G. The Asian continent has other up-and-coming countries, such as Singapore. We should not forget Japan in particular, which is the third-largest economy. So we will take a look at three companies from the Asian region.
Read
Commented by Stefan Feulner on August 4th, 2021 | 12:21 CEST
Evotec, Barsele Minerals, Nikola - When will the starting signal follow?
It has become quiet on the gold market. After the emerging fears of possible interest rate hikes due to rising inflation, the precious yellow metal remains in the range of around USD 1,800 per ounce. The price should be significantly higher due to the continued ultra-loose monetary policy of the central banks and the highs in government debt. Given that a slowdown in bond purchases or even larger interest rate hikes is hardly possible, a rise in the gold price can barely be avoided in the long term. The opportunity for an anticyclical entry is still given.
Read
Commented by Stefan Feulner on August 4th, 2021 | 11:54 CEST
BMW, NSJ Gold, Infineon - Enormous demand
In recent months, the shortage of semiconductors has been a major headache for the manufacturing sector, especially for carmakers. Production losses and short-time work were the result of the global shortage. There seems to be no improvement in sight. Leading chip manufacturer Intel expects the chip shortage to worsen in the coming months and does not expect the situation to ease for at least two years. There is a similar shortage of raw materials for the energy transition. Position yourself in good time.
Read
Commented by André Will-Laudien on August 4th, 2021 | 11:23 CEST
MorphoSys, Defence Therapeutics, BioNTech, Pfizer - The next biotech explosion!
Infectious diseases are diseases transmitted by pathogens such as bacteria, viruses or fungi. Depending on which organs and body parts they affect, they can cause very different symptoms. In Covid-19, we are dealing with a problematic initial situation because not every infected person has apparent symptoms at all. Moreover, the virus can also be transmitted from vaccinated individuals to the next host without any problems. That shows the high relevance of testing, despite increasing vaccination rates. On the one hand, the biotech sector is concerned with diagnostic procedures and, on the other hand, with suitable vaccinations to best prepare our immune system for the fight. In the current pandemic, the coming winter will also indicate the overall effectiveness of vaccines.
Read
Commented by André Will-Laudien on August 4th, 2021 | 11:10 CEST
XPhyto Therapeutics - Groundbreaking diagnostic platforms of the future
The number of infectious diseases that we humans are fighting today has increased significantly in recent decades, not just because they have become known and researched. Increasingly frequent variants and neoplasms have also led in turn to entirely new disease patterns. An important area upstream of the medical sector is the large diagnostics market. The umbrella term of diagnostics is used in particular in the context of the detection and differentiation of diseases. This is referred to as clinical diagnostics. Many test and diagnostic procedures are assigned to the bioscience sector since studies must first prove their exact validity. Worldwide, more than 10,000 companies are involved in symptom research, the detection, screening and analysis of the diagnosis of diseases.
Read
Commented by Carsten Mainitz on August 4th, 2021 | 10:11 CEST
Defense Metals, BYD, Nordex - Buy the trend!
Whether a laptop, cell phone, electric motor or wind turbine - rare earths are an indispensable raw material for producing all these goods. The megatrends of electromobility and renewable energies, in particular, are fuelling demand. Motors for electric vehicles and generators for wind power plants require powerful permanent magnets, and this is where rare earths such as neodymium and dysprosium come into play. We show you how to profit from this trend.
Read
Commented by André Will-Laudien on August 3rd, 2021 | 13:41 CEST
Nordex, Silver Viper, Siemens Energy - Watch out for storm warnings!
Since the last flood disaster in Germany, the political pressure for more climate protection has been palpable. The final realization comes late, and at the same time, it is a bit sad what has to happen before lip service turns into new laws. But the pace is now clear: decarbonization and new climate targets will determine global economic activity, and those who pollute the atmosphere will have to accept high payments in the future. In other words, sustainable business is all the more worthwhile because the "cleaners" will be credited for what others pay more. In this way, incentives are created for sustainable business models. We take a closer look.
Read
Commented by Stefan Feulner on August 3rd, 2021 | 13:12 CEST
Amazon, Aspermont, Zoom - Economies of scale without end
The reporting season is in full swing. While e-commerce giant Amazon disappointed both investors and analysts with a weak outlook, Apple and Tesla came up with better than expected numbers. Unnoticed by the mainstream, a publishing company is evolving into a media technology company with unlimited scaling potential. Be there from the start to profit from the next Amazon.
Read
Commented by Stefan Feulner on August 3rd, 2021 | 12:22 CEST
Siemens Healthineers, Cardiol Therapeutics, BioNTech - Tomorrow's blockbusters
The fight against the coronavirus and the possible return to everyday life promises companies in the biotechnology sector billions in profits. At the forefront, vaccine producers such as BioNTech with its pharmaceutical partner Pfizer or Moderna are the primary beneficiaries of the pandemic. In addition, start-ups are emerging from the diagnostics and therapy sectors, whose formulations have blockbuster potential and could follow a similar path to the vaccine manufacturers in the coming years.
Read